SDCEP logo

SDCEP-Drugs for Management of Dental Problems During COVID-19 Pandemic – Update

SDCEP has updated the Drugs for Management of Dental Problems During COVID-19 Pandemic supplement, which was first published on 8 April 2020.  The drugs supplement is based on SDCEP’s Drug Prescribing for Dentistry guidance and lists the drug regimens that dentists are most likely to advise or prescribe for their patients during the COVID-19 pandemic.  The updated version: –

  • provides more detailed advice on contraindications and cautions for analgesics and antibiotics in two new appendices
  • clarifies the definition of optimal analgesia
  • includes volumes for oral preparations of analgesic doses for children
  • emphasises that antibiotics are not indicated in the absence of swelling or other signs of infection  

The updated drugs supplement is now available on the SDCEP COVID-19 webpage.

SDCEP’s Management of Acute Dental Problems during COVID-19 Pandemic guide and the updated drugs supplement are now also available on the SDCEP Dental Companion app. Further details are available on the SDCEP website.

Back to News index